You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for New Drug Application (NDA): 040519

✉ Email this page to a colleague

« Back to Dashboard

NDA 040519 describes DIMENHYDRINATE, which is a drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. It is available from one supplier. Additional details are available on the DIMENHYDRINATE profile page.

The generic ingredient in DIMENHYDRINATE is dimenhydrinate. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dimenhydrinate profile page.

Summary for 040519

Tradename:	DIMENHYDRINATE
Applicant:	Fresenius Kabi Usa
Ingredient:	dimenhydrinate
Patents:	0

Medical Subject Heading (MeSH) Categories for 040519

Antiemetics
Histamine H1 Antagonists

Suppliers and Packaging for NDA: 040519

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DIMENHYDRINATE	dimenhydrinate	INJECTABLE;INJECTION	040519	ANDA	Fresenius Kabi USA, LLC	63323-366	63323-366-01	25 VIAL in 1 TRAY (63323-366-01) / 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	50MG/ML
Approval Date:	Jun 23, 2004	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.